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There is a growing consumer segment demanding healthy foods and diets, health 
and nutrition messages can expand food demand, and governments in the U.S. and 
EU, faced with increasing obesity and associated health outcomes, want consumers 
to have reliable information to choose healthy diets.  California commodity 
organizations, charged with expanding the demand for almonds, avocados, 
strawberries and walnuts, are funding health and nutrition research as a means to 
discover a unique selling proposition for each product. Research and promotion 
effects are attracting interest by other commodity groups.  Policy and regulatory 
issues abound.   
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Sharply increasing numbers of consumers who are selecting food based on health 
and nutritional attributes are an international phenomenon fueled by a number of 
factors.  Included are increasing consumer incomes with a decreasing share spent 
on food, globalization of food supplies, worldwide health problems associated with 
diet (including obesity, heart disease, diabetes, and cancer), increased introductions 
of “new” processed food products, food safety incidents, and a proliferation of 
information and health claims by producers, processors, commodity organizations 
and other groups attempting to expand demand for their products.  This increased 
emphasis on food attributes poses a series of issues and opportunities for food 
systems around the world. 
 
Growing consumer concerns about the health attributes of food products, improving 
awareness about the possible impacts of diet on health, and growing demand for 
functional food products has been met with increased information and, sometimes 
misleading promotion concerning product attributes. In response, the U.S. Food and 
Drug Administration and the European Commission have issued and proposed new 
rules directed at inaccuracies, confusion, and false information related to the 
functional and disease risk reduction claims on food packaging and in commodity 
promotional materials. Several U.S. commodity groups are funding health and 
nutrition research programs to support health claims for their products.  These 
actions raise policy questions regarding the appropriate bodies to be conducting 
health and nutrition research for food products, the nature of expected returns from 




This paper has three objectives.  They are to: 
 
1.   Summarize the evolution of U.S. and EU rules for health claims on food. 
2.  Present case-study examples of health and nutrition research and promotion 
programs conducted by California commodity organizations. 
3.  Outline some policy issues related to health and nutrition research by 




Food production and marketing firms operate within a political environment that 
includes laws, regulations, government agencies and pressure groups that affect 
decision-making and profitability.  Both the U.S. and the E.U. have laws and 
regulations covering issues such as competitive behavior, fair trade, truth in 
advertising, product standards, packaging and labeling and other important areas 
to protect consumers and prevent unfair competition.  The political environment 
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changes over time in response to changes in economic, cultural and demographic 
forces.  This study examines changes currently underway in laws and regulations 
affecting health and nutrition claims for food products in the U.S. and E.U.  Widely 
used terms such as low fat, calorie free, and light have been defined and health 
claims must be based on sound scientific findings.  Case studies of four California 
commodity organizations’ health research and promotion programs, based on 
interviews with management, demonstrate actions taken to develop research data 
for promoting their commodities.  These case studies document the research topics 
funded, the allocations of producer funds for health research, and the use of 
research results to obtain qualified health claims and promotion strategies based on 
health research results.  Policy issues associated with the development of health 




The U.S. Government and the European Commission have both found it necessary 
to develop and issue rules concerning health and nutritional claims for food 
products as an attempt to reduce the confusion facing a consumer attempting to 
select a “healthy diet” for his or her family. As pointed out by Michael Pollan in a 
New York Times article, “Once, food was all you could eat, but today there are lots 
of other edible food-like substances in the supermarket.  These novel products of 
food science often come in packages festooned with health claims …. “.  Prior to the 
issuance of rules and definitions, consumers faced an array of manufacturer product 
claims concerning fat, calories, cholesterol, sugar, sodium, and various nutrients 
using undefined terms such as “fat free,” “90% fat free,” “reduced fat,” and 
“light/lite”. Continued attempts by governments to reduce misinformation and 
confusion in the marketplace are often controversial with both consumer advocates 
and food manufacturers criticizing the rules.  Following is a brief description of the 
evolution of U.S. Food and Drug Administration (FDA) and European Commission 
regulations regarding health and nutrition claims for food products.   
 
U.S. Government Regulations 
 
The FDA and the Federal Trade Commission (FTC) share authority to regulate the 
health information that food manufacturers and marketers place on labels and in 
their advertising.  The FDA regulates health claims and authorizes nutrient content 
claims for food products while the FTC has authority over advertising messages and 
enforces “truth in advertising” for all business entities.  Note that an advertising 
claim that satisfies applicable FDA requirements will typically satisfy FTC 









The Nutrition Labeling and Education Act (NLEA) of 1990, gave the FDA specific 
authority to permit health claims in the labeling of foods, where health claims are 
always phrased in terms of "may reduce the risk of" some disease or health-related 
condition and not about treating, mitigating or curing diseases (Nickerson).  Prior to 
Congressional action, foods that had certain science-backed claims about disease 
prevention in their labeling risked being regulated as drugs (defined as articles 
intended for use in the diagnosis, cure, mitigation, treatment or prevention of 
disease in man).  There are two types of health claims, unqualified health claims 
and qualified health claims.  Both require detailed FDA review of scientific evidence 
submitted in a health claim petition.   
 
Unqualified health claims are also referred to as SSA health claims, where SSA 
stands for significant scientific agreement, and that comes from the Nutrition 
Labeling and Education Act's standard for FDA to authorize health claims by 
regulation. It is significant scientific agreement among qualified experts 
(Nickerson).  For example, the unqualified health claim for low sodium foods and 
high blood pressure reads: “diets low in sodium may reduce the risk of high blood 
pressure, a disease associated with many factors.”   
 
Qualified health claims are health claims that are based on scientific evidence that 
is credible but that does not meet the significant scientific agreement standard. 
These health claims include a disclaimer or other qualifying language to prevent 
consumers from being misled about the level of support for the claim or other 
important facts, which could be, for example, conditions of use that are necessary to 
obtain the risk-reduction benefit. Qualified health claims are considered under 
FDA's exercise of enforcement discretion (Nickerson).  The health claims secured 
through petition by California commodity organizations, to date, are qualified 




The FDA regards statements addressing dietary patterns or general categories of 
foods and health to be dietary guidance rather than health claims.  Dietary 
guidance statements made on food labels must be truthful and not misleading, but 
do not require submission or notification to FDA.  Claims about the effect of a food 
on the normal function or structure of the human body (structure-function claims) 
are also outside the FDA submission process.  An example of a structure-function 
claim is that “calcium builds strong bones.”  These claims cannot link a specific 
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Nutrient Content Claims 
 
The Nutrition Labeling and Education Act also permits use of authorized “nutrient 
content claims,” which characterize the level of a nutrient in a food.  These claims, 
which must be in accordance with FDA’s authorizing regulations, can describe the 
level of a nutrient or dietary substance quantitatively or by using terms relative to 
an absolute such as free, high, low, or a good source.  For example, FDA regulations 
define “calorie free” as less than 5 calories per serving, “fat free/sugar free” as less 
than ½ gram fat or sugar per serving, “low calorie” as less than 40 calories per 
serving, and “light” as 1/3 fewer calories or ½ the fat of the usual food (Mehlberg). 
 
European Commission Regulations 
 
European and American consumers have experienced the same issues regarding 
health and nutrition claims for food products, but European regulators have been 
faced with the additional problems of dealing with diverse national rules.  The 
European Commission put forward the proposal for the Health Claims Regulation 
on July 16, 2003 and on June 3, 2005 EU health ministers unanimously endorsed 
the Commission's proposal, including the provision for nutrient profiles and the 
authorization procedure, during a first reading vote at the Health Council.  Then on 
May 17, 2006 the European Parliament gave its support to the Health and 
Nutrition Claims Regulation, in its 2nd reading.  Final adoption of the Regulation 
on Health and Nutrition Claims by the Council of Ministers was on December 20, 
2006. 
 
Regulation on Health and Nutrition Claims 
 
Health & Consumer Voice, the European Commission’s newsletter (Jan. 2007) 
states:  “The new legislation on health and nutrition claims will ensure that any 
claim made on a food label in the EU is clear, accurate and substantiated. Strict 
conditions are laid down for the use of nutritional claims such as "low fat", "a good 
source of protein" or "reduced sugar", and only foods that are consistent with agreed 
nutritional profiles will be allowed to carry such claims.  For health claims, the 
Commission will draw up a positive list of well-established claims, such as "calcium 
is good for your bones", which may be used on a label as long as they are proven to 
apply to the food in question. New health claims or disease reduction claims, such 
as "reduces the risk of cardiovascular diseases" or "reduces the risk of osteoporosis", 
will have to undergo a specific authorization procedure before they can be used.”  
Provisions in the Regulation are effective on July 1, 2007.   
 
The European Food Safety Authority is charged with carrying out a scientific 
assessment of the evidence submitted to support health claims.  The Regulation 
(2006) states that, “Health claims should only be authorized for use in the 
Community after a scientific assessment of the highest possible standard.”  It adds 
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that, “In order to ensure that health claims are truthful, clear, reliable and useful to 
the consumer in choosing a healthy diet, the wording and the presentation of health 
claims should be taken into account in the opinion of the European Food Safety 
Authority and in subsequent procedures.”  Note that disease reduction messages, 
currently prohibited by EU legislation, would be possible under new rules if they 
could meet the scientific standards for substantiation.   
 
The Annex to the Regulation on Health and Nutrition Claims (2006) includes a 
rather extensive list of nutrition claims and conditions that must be satisfied to use 
them.  These claims include, for example, low energy, low fat, low sugar, low 
saturated fat, low sodium-salt, fat-free, saturated fat-free, sugar-free, energy-free, 
sodium-free, salt-free, source of protein, source of [named vitamins or minerals], 
natural, light/lite, etc.   
 
Given the similar goals for the U.S. and European regulations for health and 
nutrition claims for food products, it is not surprising to find similar terms, 
requirements, and procedures.  The European Regulations, which include 
provisions for adjustments from existing national rules, are not fully effective for 
several years.  In addition, the European Regulations may be more restrictive than 
U.S. rules in that they do not appear to allow for the qualified health claims 
approved by the FDA.  This will depend on the standards for approval developed 
and used by the European Food Safety Authority. 
 
Sources of Scientific Evidence 
 
The relatively recent adoption of nutritional and health claims standards for food 
places new pressures on producer organizations and food manufacturers to conduct, 
fund, or lobby government for funding health research. The perceived value of a 
health and nutrition message for expanding product demand provides an economic 
incentive for firms and commodity groups to support health and nutrition research.  
Acquiring the research necessary for a health or nutrition claim, however, can be a 
long and expensive process.  Following are case studies of health and nutrition 
research and promotion programs conducted by the Almond Board of California, the 
California Avocado Commission, the California Strawberry Commission, and the 
California Walnut Commission.1 Each of these commodity groups is funding 
research to determine the health attributes of their products and then using 
research results in their public relations and promotional programs. The research 
and promotional programs for the four commodities will be compared and 
contrasted.  The potential contributions of producer-funded research and promotion 
of healthy diets will be outlined.  Successful programs for the case study 
                                                           
1 The Almond Board is a Federal Marketing Order and the three State Commissions each have their 
own separate enabling legislation.  All four programs were established by a 2/3 vote of covered 
producers and participation is mandatory for all California producers of each commodity.    
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The California Walnut Commission (CWC) was one of the first commodity groups to 
fund health and nutrition research when it decided to counter diet 
recommendations urging consumers to reduce or constrain consumption of nuts 
because of their high oil content.  The CWC funded their first project on the 
protective effect of nut consumption on the risk of coronary heart disease with 
researchers at Loma Linda University in 1990.  The Almond Board of California 
(ABC) established a Nutrition Research Program and Nutrition Subcommittee in 
1995 to review the scientific validity of proposals and recommend studies for 
funding.  During 1997, the California Avocado Commission (CAC) made a strategic 
change to proactively communicate the nutritional benefits of avocados through 
national public relations/outreach efforts.  The California Strawberry Commission 
(CSC) began funding nutrition research proposals in 2003. Results from this 
research are being used in the CSC advertising and promotion programs. 
 
The four commodity groups each have analyses detailing their chemical and 
nutritional composition, including such things as amount and type of fat, calories, 
vitamins, phytochemicals, antioxidants, minerals, etc.  The presence of particular 
components, already associated with favorable health outcomes, has helped focus 
research on important health topics.  Health and nutrition research topics pursued 
by the four commodity groups have similarities as well as differences (Table 1).  
Each commodity group has or is seeking evidence on the value of consuming their 
product on reducing the risk of heart disease.  Each group has evidence that product 
components may lower the risk of certain cancers and each of the commodities 
 
Table 1: Current Health and Nutrition Areas of Interest Mentioned by Four 
California Commodity Groups 
Commodity  Research Area 
Almonds Avocados  Strawberries  Walnuts 
Cardiovascular Disease  X  X  X  X 
Weight & Obesity  X  X    X 
Cancer Prevention  X  X  X  X 
Diabetes X  X    X 
Antioxidants X  X  X  X 
Aging X  X  X  X 
Prostate Health        X 
Bone Health        X 
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contains antioxidants that are known to slow the aging process and protect against 
heart disease and various forms of cancer.  Almonds, avocados and walnuts can be a 
component of diets to control weight gain and each can be part of a diet for 
managing and controlling diabetes.   
 
Expenditures on health and nutrition research by almond, avocado, strawberry and 
walnut producers have been substantial.  A review of budgets for the five-year 
period 2001/02 to 2005/06 indicates that these four commodity groups spent a total 
of over $9.08 million on health and nutrition research.  The most recent budgets 
show annual expenditures on health and nutrition research of $1,000,000 by the 
ABC for almonds, $605,000 by the CSC for strawberries, and $1,468,857 by the 
CWC for walnuts. Each commodity group has formed a nutrition or scientific 
advisory committee that includes well-known and knowledgeable nutritionists and 
medical researchers to provide ideas and advice on research areas, nutrition based 
programs, and outreach efforts.  Each commodity also maintains a website that 
provides detailed information on the nutrition/health benefits of consumption of the 
commodity and each has a nutritionist on staff or on retainer.    
 
Results from commodity-group sponsored health and nutrition research is 
accumulating, as illustrated by a summary posted by the California Walnut 
Commission (CWC) for walnuts.  The CWC began with studies on the relationships 
between walnut consumption and cholesterol levels and walnut consumption and 
the risk of coronary heart disease.  The CWC funded epidemiological and clinical 
studies at universities in the U.S., France, New Zealand, Spain, Norway, and 
Japan.  Results of these studies, published in medical, nutrition, and scientific 
journals, indicate that consumption of walnuts improves the function and reduces 
inflammation in arteries, reduces LDL cholesterol, reduces blood pressure and 
reduces heart disease risk.  There is also evidence that melatonin in walnuts 
protects against cancer and heart disease, that walnuts can help in weight 
management, that consumption of walnuts are protective for people with type 2 
diabetes, and that the form of vitamin E found in walnuts might halt the growth of 
lung and prostate cancer cells. Walnuts have high concentrations of antioxidants, 
which help the body ward off life-threatening maladies such as cancer, heart disease 
and diabetes, as well as debilitating ailments such as arthritis, osteoporosis and 
Alzheimer’s disease (CWC, p. 6).   
 
The Almond Board of California (ABC) initiated its nutrition research program in 
1995, with funding of $300,000 for studies on cardiovascular disease, decreased 
cancer risk, glucose metabolism, and analysis of the nutrient content of almonds.  
Both funding and the number of studies increased rapidly.  Now, with annual 
health research budgets of over $1 million, the ABC has ongoing research 
relationships with more than 20 scientific organizations and universities around the 
world.  In terms of research support, the topic with the largest budget is 
cardiovascular research (24%), followed by research on the composition of almonds 
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(20%), research on antioxidants (19%), cancer research (14%), and research on 
weight (3%).  The website www.almondsarein.com lists 11 ongoing almond nutrition 
research projects on topics in the above areas.  Research topics include food allergy, 
Vitamin E content, analysis of the chemical composition of almond skins, colon 
cancer, cholesterol levels and reduction, the effect of almonds on glycemic control 
and insulin response, and the effects of almond consumption on appetite, energy 
and weight.  The website lists references for 37 publications reporting nutritional 
characteristics and research results on potential health benefits of consuming 
almonds.   
 
Qualified Health Claims 
 
Both almonds and walnuts have secured FDA qualified health claims, the 
strawberry research program has a stated goal of obtaining a qualified health claim, 
and the CAC’s Nutrition Advisory Committee is researching new and necessary 
information, timing and feasibility to submit a qualified health claim about 
avocados and heart health to the FDA (CAC, Oct. 2006).  The CAC writes that they 
expect the process to take about three to five years (p. 58).   
 
The International Tree Nut Council Nutrition Research and Education Foundation 
petitioned the FDA to authorize a health claim about the relationship between the 
consumption of nuts and reduced risk of coronary heart disease (CHD) on the label 
or in the labeling of whole or chopped nuts and certain nut-containing products.2  
The petition contained two model health claims (FDA, 2003): 
 
1.  Diets containing one ounce of nuts per day can reduce your risk of heart 
disease. 
2.  Eating a diet that includes one ounce of nuts daily can reduce your risk of 
heart disease. 
 
The FDA concluded that there is not significant scientific agreement that 
consumption of nuts may reduce the risk of coronary heart disease and declined to 
authorize a health claim. The FDA did conclude, however, that that there is a 
sufficient basis for a qualified health claim about nuts and reduced risk of CHD, 
and approved the following qualified health claim and disclosure statement on July 
14, 2003 (FDA, 2003):  
 
"Scientific evidence suggests but does not prove that eating 1.5 ounces 
per day of most nuts [, such as name of specific nut,] as part of a diet low 
                                                           
2 The petition named peanuts and nine tree nuts, including almonds, Brazil nuts, cashew nuts, 
hazelnuts, macadamia nuts, pecans, pine nuts, pistachio nuts, and walnuts, as appropriate for the 
claim. 
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in saturated fat and cholesterol may reduce the risk of heart disease. 
[See nutrition information for fat content.]" 
 
The CWC submitted a separate petition to the FDA for a model health claim for 
walnuts stating, "Diets including walnuts can reduce the risk of heart disease." In a 
letter dated March 9, 2004, the FDA concluded that: “Based on FDA's reassessment 
of the scientific evidence subsequent to our initial July 14, 2003 qualified health 
claim enforcement discretion decision, the agency still concludes that there is not 
significant scientific agreement that the claim "Diets including walnuts can reduce 
the risk of heart disease" is supported by the totality of publicly available scientific 
evidence. Thus, FDA will consider exercising enforcement discretion for a qualified 
claim as presented below (FDA, 2004): 
 
 “Supportive but not conclusive research shows that eating 1.5 ounces 
per day of walnuts, as part of a low saturated fat and low cholesterol diet 
and not resulting in increased caloric intake, may reduce the risk of 
coronary heart disease. See nutrition information for fat [and calorie] 
content.” 
 
The FDA ended its response to the walnut petition with the statement: 
 
“Please note that scientific information is subject to change, as are 
consumer consumption patterns. FDA intends to evaluate new 
information that becomes available to determine whether it necessitates 
a change in this decision. For example, scientific evidence may become 
available that will support significant scientific agreement or that will 
no longer support the use of a qualified claim, or that may raise safety 
concerns.” 
 
It is interesting to note that nutrition and health research budgets for the ABC and 
the CWC have increased since approval of qualified health claims for nuts and 
walnuts.  Several factors support continued interest in nutrition and health 
research.  Consumer interest in diet and health is growing and is impacting food 
choices.  Each of the four California commodity groups has discovered that results 
from nutrition and health research can support a highly productive public relations 
effort.  Media news reports and stories on these research results are low cost and 
have the additional benefit of being more believable than advertising to many 
people. Commodity group leadership and membership are confident that their 
research programs yield high returns through increased demand for their products.  
Anecdotal evidence lends support to these views.  The walnut industry points to the 
positive impact on demand of McDonald’s decision to add fruit and walnut salad as 
a menu item, a decision that was heavily influenced by results of CWC nutrition 
and health research.  There is also solid evidence of increasing demand for avocados 
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and almonds attributable to advertising and promotion, some of which is based on 
health and nutrition topics.   
 
Nutrition and Health Promotion Strategies 
                               
While the research thrusts for the four groups are similar, their advertising and 
promotion strategies differ. The ABC first emphasized public relations for their 
health message and then shifted almost all advertising and promotion to a health 
message after the FDA issued the qualified health claim for nuts. The ABC 
partnered with the American Heart Association and focused on promotion of 
California almonds as part of a heart-healthy diet. The CSC has focused all 
consumer communications on a health message for strawberries since initiation of 
their nutrition and health research program in 2003.  The CAC continues to use 
only public relations for their health message to avocado consumers and targets 
health and nutritional professionals with promotional materials.   
 
The CWC continues to emphasize public relations activities for the health benefits 
of walnuts after laboratory testing of advertising themes found that the message on 
the health benefits of walnuts is best communicated through a third party such as a 
magazine, newspaper, doctor, nutritionist or other credible source (CWC Summer 
Report, June 2001, p. 2).  While advertising in Germany, Italy, Spain, Japan has 
included health as one of the messages, the advertising emphasis has been on 
quality, taste, and uses for walnuts in meal preparation, with public relations used 
for the health and nutrition message.3
 
Overall, consumer and media interest in diet and health issues appears to assure 
cost effectiveness for public relations programs.  For example, the ABC increased 
public relations expenditures to $1 million during 1998-1999, but estimated that the 
advertising value equivalency of exposures related to the health benefits of 
consuming almonds increased to $7 million.  The CWC estimates that publicity 
generated as a result of the FDA ruling on the qualified health claim for walnuts 
generated over 70 million impressions by the end of the 2003-04 crop year from 
news stories, magazine articles, and associated publicity on diet and health.  Media 
impressions attributed to the CWC public relations program in the U.S. increased 
from a little over one billion in 2001-02 to over two billion in 2004-05 at a cost per 
million impressions that decreased from $0.59 in 2001-02 to $0.37 in 2004-05 (CWC, 
2006). 
 
Partnering by the ABC, the CAC, and the CWC with other organizations, such as 
the American Heart Association, the Spanish Heart Foundation and the American 
                                                           
3 A review of CWC newsletter reports provides information on promotional activities in major export 
markets, including Canada, Germany, Italy, Spain, Israel, Japan, and Korea, 
http://www.walnuts.org/news/new_nletters.asp 
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Diabetes Association, provides product exposure in diets offering particular benefits 
such as heart healthy diets, healthy food choices for diabetics, or weight control 
diets.  The funds allocated to nutrition research by each organization tend to add to 
total research rather than substitute for traditional research on production and 
post-harvest problems.   
 
Published health and nutrition research results have been a positive factor in 
having almonds, avocados, strawberries and walnuts included in dietary 
recommendations by various organizations and agencies.  As noted by the CWC, for 
example, a key recommendation of the 2005 Dietary Guidelines for Americans, 
announced in January 2005 by the USDA and U.S. Department of Health and 
Human Services is for consumers to consume more polyunsaturated fat  (and less 
saturated and trans fat).  Special emphasis was given to increasing intake of 
essential fatty acids, including omega-3 fatty acids, specifically noting plant sources 
of omega-3 fatty acids such as walnuts.  This recommendation is consistent with 
recommendations of the American Heart Association, the U.S. Food and Drug 
Administration, and the National Academy of Sciences.  This recommendation is 




The significant expenditures on health and nutrition research by government 
sponsored commodity organizations and the approval of qualified health claims by 
the FDA have raised a number of questions.  The EU’s new Regulation on Health 
and Nutrition Claims is also a source of controversy.  Following is a brief discussion 
of some of the issues being discussed.  
 
Some agricultural producers argue that commodity organizations should not spend 
their mandatory assessments on health and nutrition research while others point to 
the positive impact of research results on product demand.  Producers have a long 
history of supporting production research but very little experience with health and 
nutrition research.  Government sponsorship of research through the agricultural 
experiment stations is well accepted and, while producers have developed an 
appreciation for the need to provide funding to help direct production research, the 
need or opportunities for health and nutrition research were not appreciated.  As 
one might expect, producer opposition was much stronger before research results 
were available.  Now several commodity groups are considering health and 
nutrition research programs as a possible way to expand product demand.  Critics 
also point to the possible problem of a commodity organization not supporting 
research or suppressing research results that are unfavorable to their interests’, a 
criticism that could apply to any privately sponsored research.  Open and widely 
circulated requests for proposals (RFP’s) and the execution of contracts with 
Universities, where faculty expect to publish their research results, helps to 
minimize the problem of suppressing results but not the selection of projects.  
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Supporters of commodity- organization-sponsored health and nutrition research 
have argued convincingly that the research is in their interest and if they do not 
provide financial support, it will not get done.   
 
The question of “who benefits from health and nutrition research” is relevant.  The 
producers funding the research obviously believe that the research is yielding 
positive benefits or they would reduce rather than increase expenditures. 
Commodity organizations funding health and nutrition research, however, face a 
potential free rider problem in a global economy.  For example, the results of health 
and nutrition research funded by California almond and walnut producers will 
apply to almonds and walnuts regardless of where they might be produced. This 
may not be a serious problem for California almond producers, who account for the 
majority of world almond production but it may be important for producers of a 
commodity with a smaller market share that faces competition from other countries 
in both domestic and export markets. Firms that are able to obtain patent or 
trademark protection on products of their research programs may be able to capture 
the majority of benefits.  Economic theory argues that improved information will 
benefit consumers and improve economic efficiency.  Consumers can benefit from 
information that is used to make diet choices that lead to improved health 
outcomes.  These benefits include “feeling better,” reduced medical care, increased 
life spans, improved labor productivity, and all of the other personal and economy-
wide payoffs accruing from a healthier population.   
 
The FDA’s approval of qualified health claims, which is the result of a legal ruling 
related to First Amendment rights, is controversial.   Food manufacturers know 
that health claims can help product sales, even if the science supporting the claim is 
not strong.  They argue that consumers should have access to emerging science. 
Critics believe that qualified health claims are confusing and not well understood by 
consumers.  This view tends to be supported by FDA research.  Derby and Levy 
(2005) asked people to look at a hypothetical product and an accompanying health 
claim that was similar to those carried by real products.  Two of the four products 
included were a fake tuna product with a claim that the omega-3 fatty acids may 
help fight heart disease and a spaghetti sauce with a claim that lycopene could help 
fight cancer.  An FDA “Questions and Answers” sheet on the findings of the Derby 
and Levy study summarizes the results as (Sept. 28, 2005):  
 
1. “Qualifying statements that used only words to convey the strength of 
science underlying a claim were not understood by consumers.”  
2. “Qualifying statements that included a "report card grade" were 
understood by consumers to convey a rank order of the strength of 
science underlying a claim, but ‘B' grades were understood to convey 
greater scientific certainty than unqualified health claims (i.e., claims 
that meet the significant scientific agreement standard).  (In the FDA 
consumer research study, FDA did not use an "A" letter grade for the 
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experimental conditions representing claims that met the significant 
scientific agreement standard, but simply stated the substance/disease 
relationship.)” 
3. “Even when qualified health claims were understood as intended, 
qualifying statements had unexpected effects on consumers' judgments 
about the health benefits and overall healthfulness of the product 
bearing the claim. Sometimes, these qualified health claims led to more 
positive product perceptions.” 
 
After releasing the results of the Derby and Levy study, the FDA held a meeting on 
November 17, 2005 to assess consumer perceptions of health claims.  A transcript of 
the meeting is available at http://www.cfsan.fda.gov/~dms/qhctran.html#qhc. 
 
The EU Regulation on Health and Nutrition Claims was adopted by the Council of 
Ministers on December 20, 2006 and is effective July 1, 2007. The stated objectives 
of the Regulation are to achieve a high level of consumer protection, to improve the 
free movement of goods within the internal market, to increase legal security for 
economic operators, and to ensure fair competition in the food sector. The 
Regulation covers voluntary nutrition and health claims made on foods; labeling, 
presentation and advertising; trademarks and brand names.  Provisions of the 
regulation will be phased in over time.  Presently it appears that all health claims, 
which must be approved by the European Food Safety Authority (EFSA), will be 
based on and substantiated by generally accepted scientific evidence.  There do not 
appear to be any provisions that allow for U.S. type “qualified health claims.”  An 
early task for the EFSA is to consult on establishing a Community positive list of 
permitted health claims. This list will be derived from the various lists of claims 
based on generally accepted evidence that are being compiled by member states.  
Companies wishing to use health claims not on the positive list are required to 
prepare applications that include evidence for a particular health claim.   
 
The development and approval of the EU Regulation on Health and Nutrition 
Claims was controversial and its implementation is guaranteed to spark 
controversy.  A news account in the Guardian Unlimited about issues involved 
when the regulation of food health claims was proposed helps to outline some points 
of contention (2003).  The news story reported: 
 
 ”Heavy lobbying is expected from food manufacturers who have argued 
that new rules would hit consumer choice and hurt business.  The 
European Breakfast Cereal Association described the proposed 
measures as overly restrictive and not proportionate to the objective 
pursued.”  On the other side, Sue Davies of the Consumers Association 
said: “There are vast numbers of products on the shelves promising 
health claims but it has always been impossible for consumers to 
distinguish between the real and the bogus.  This is a great victory for 
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consumers but it is only the first hurdle.  We have a long way to go 
before we see these much-needed changes on the shelves.”   
 
The European Food Safety Authority will face political pressure from both sides of 
the table.  Food manufacturers whose long-standing claims are not approved will 
protest, as will policy makers intent on combating obesity and improving diets.  
Manufacturers may face significant financial and time commitments to develop the 
scientific evidence needed for approval of a health claim.  There is concern that 




Health and nutrition claims for food products can be a very effective marketing tool.  
This has encouraged some firms to use misleading, dubious and just plain false 
claims in their labeling and promotion that has led to government action and 
regulation in many countries.  The U.S. and EU now have rules in place requiring 
approval for health claims based on sound scientific evidence before such claims are 
used.  In the U.S., the FDA is examining ways to clarify the meaning of 
qualifications to permitted health claims while in the EU, regulations are just 
becoming effective.  The objective is to provide reliable information to guide 
consumers’ healthy food choices.   
 
Commodity groups are sponsoring nutrition/health research and promotion with the 
objective of increasing demand for their products.  As part of this process they are 
adding to the research base on nutritional components of food products, beneficial 
effects of particular food components, and food component-disease interactions.  
They are also communicating the results to health and nutrition professionals and 
consumers in their outreach programs.  Their programs appear to have a positive 
impact on product demand and there is increasing interest in discovering new 
health and nutrition benefits from consuming many commodities, including apples, 
blueberries, cranberries, kiwifruit, milk, and table grapes, to mention a few.   
 
Actions taken regarding health research/promotion programs by the commodities 
listed above and others will be affected by the: (1) availability of research/promotion 
funds; and (2) the perceived returns for health research and promotion relative to 
other marketing program expenditures.  There are potential developments that can 
have significant impacts on both funds and perceptions of returns.  For example, 
according to Secretary of Agriculture Johanns, the USDA’s 2007 farm bill proposals 
for specialty crops includes $5 billion in additional targeted funding to address 
market promotion, sanitary and phytosanitary issues, nutrition, and targeted 
research (May 7, 2007).  If these proposed funds are included in the final 2007 Farm 
Bill, there will be additional funds available for health/nutrition research and 
promotion programs for specialty crops.  Will they be spent for health/nutrition 
research? 
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Regarding use of funds, the following perceptions of commodity group fund 
allocation to alternative programs, based on a simple competitive markets model, 
are subject to research verification.  They are: (a) production research reduces costs 
of production, thus increasing supply and decreasing price.  For some supply and 
demand elasticities, this effect can reduce total returns and actually harm 
producers; (b) simple generic advertising programs increase demand, but the effect 
is not permanent. There may be lagged effects from generic advertising but the total 
effect appears transitory.  Producers benefit when demand is higher but demand 
shifts back when the effect wears off; and (c) nutrition research plus promotion of 
nutrition benefits has a positive impact on product demand rather than supply and 
the discovery and promotion of health benefits may permanently shift demand and 
price to a higher level.  If the above relationships hold, then (c) will be a better use 
of marketing program monies than (a) or (b).  There are indications that a 
promotion message based on diet and health is more effective than the typical 
generic message on location of production, product availability, or flavor but this 
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